ArticleCureus2026
Ischemic Type of Central Vein Occlusion in a Patient With Bietti Crystalline Dystrophy: A Longitudinal Follow-Up of 12 Years.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bietti crystalline dystrophy (BCD) is a rare chorioretinal dystrophy associated with mutations in the CYP4V2 gene, characterized by intraretinal crystalline deposits and progressive chorioretinal degeneration. Retinal vein occlusion (RVO) is exceedingly rare in BCD, with only one previously reported case of tributary RVO without a detailed clinical description. We hereby describe a 44-year-old man with genetically proven stage 2 BCD who developed right central RVO (CRVO) eight years following the initial diagnosis in 2013. Though he did not notice any new visual disturbance in the right eye, routine fundus examination revealed subtle peripheral microvascular abnormalities and intraretinal small hemorrhages 360 degrees in 2021, and fluorescein angiography demonstrated nearly 360-degree peripheric nonperfusion with scattered microaneurysms, consistent with the diagnosis of ischemic CRVO. Four years later, the patient developed peripheric retinal neovascularizations and a small preretinal hemorrhage in his right eye that was managed solely with scatter laser photocoagulation. Unlike a previously reported case with retinitis pigmentosa and CRVO, in which neovascular complications did not arise, most likely due to extensive peripheral chorioretinal atrophy related to low VEGF levels, our case exhibited less peripheral chorioretinal atrophy; therefore, peripheral ischemia led to the development of retinal neovascularizations. Patients with BCD may not perceive peripheral retinal alterations due to their already compromised central vision; therefore, regular clinical visits seem beneficial to detect potential fundus changes promptly, as demonstrated in the present case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.